Pharmaceutical composition for treating blood-heat bleeding type acute idiopathic thrombocytopenic purpura and preparation method of pharmaceutical composition

Abstract

The invention discloses a pharmaceutical composition for treating blood-heat bleeding type acute idiopathic thrombocytopenic purpura and a preparation method of the pharmaceutical composition. The pharmaceutical composition comprises the following raw herba materials: herba andrographitis, folium isatidis, patience dock root, hyrtanandra hirta, trollflower, rulvis glycyrrhizae extractionis sedilis, houttuynia cordata, humifuse euphorbia herb, potentilla chinensis, Chinese holly, dried rehamnnia root, umbilicaria esculenta, portulaca oleracea, flos sophorae, senna, aloe, fructus cannabis, hypericum ascyron, pollen typhae, garden burnet, lalang grass rhizome, ramie root, rumex japonicus, callicarpa bodinieri, vitis bryoniifolia, radix ophiopogonis and polygonatum odoratum. The pharmaceutical composition has the beneficial effects that that the pharmaceutical composition has the advantages of rapidness to take effect, definite curative effect, high security, no toxic or side effect and low possibility of replase when being used for treating blood-heat bleeding type acute idiopathic thrombocytopenic purpura based on the traditional Chinese medicine principles and the treatment principles that heat and toxic material clearing away and blood cooling and bleeding stopping are highlighted and qi and spleen tonifying is secondarily emphasized.

Description

[0001] technical field [0002] The invention relates to a medicine containing raw materials derived from plants, animals or minerals, in particular to a medicine composition for treating acute idiopathic thrombocytopenic purpura of blood-heat rash type and a preparation method thereof. [0003] Background technique [0004] Idiopathic thrombocytopenic purpura (ITP), or idiopathic thrombocytopenic purpura, refers to the decrease of platelets caused by no obvious exogenous etiology, but most of them are due to the increased destruction of platelets caused by immune reactions, so it is also called itself Immune thrombocytopenia is a relatively common hemorrhagic blood disease, characterized by shortened platelet life span, increased bone marrow megakaryocytes, IgG antibodies in serum or platelet surface in 80%-90% of cases, and no obvious enlarged spleen. According to pathogenesis, predisposing factors and course of disease, ITP is divided into acute type and chronic type. 8...

AI Technical Summary

Problems solved by technology

However, western medicine treatment of idiopathic thrombocytopenic purpura has many adverse reactions caused by the long-term application of a large number of hormone drugs, which is prone to dependence and drug resistance.